Multidisciplinary, Political Science and International Relations, Education, Social Sciences
34294
Scholar Citations
80
Scholar h-index
794
Scholar i10-index
RECENT SCHOLAR PUBLICATIONS
Brought Forth on This Continent: Abraham Lincoln and American Immigration H Holzer Penguin Group , 2026 2026 Citations: 1
Risk factors for actinic keratosis, non-melanoma skin cancer and cutaneous malignant melanoma in persons with and without Parkinson’s disease: A cross-sectional study E Azizi, H Feuerman, I Peleg, F Pavlotsky, Z Segal, B Oberman, N Lev, ... Skin Health and Disease 4 (6), ski2. 464 , 2024 2024 Citations: 3
Pain-associated diagnoses in childhood before the diagnosis of attention-deficit/hyperactivity disorder: a population-based study E Merzon, E Magen, Y Levy, S Ashkenazi, I Manor, A Weizman, B Krone, ... Children 11 (11), 1388 , 2024 2024 Citations: 4
A discrepancy in the reports on life events between parents and their depressed children is associated with lower responsiveness to SSRI treatment M Amitai, E Etedgi, T Mevorach, R Kalimi, N Horesh, N Oschry-Bernstein, ... Journal of Child and Adolescent Psychopharmacology 34 (9), 407-413 , 2024 2024 Citations: 1
Novel TSPO Ligand 2-Cl-MGV-1 Can Counteract Lipopolysaccharide Induced Inflammatory Response in Murine RAW264. 7 Macrophage Cell Line and Lung Models F Obeid, M Kahana, B Dahle, S Monga, Y Zohar, A Weizman, M Gavish Cells 13 (20), 1702 , 2024 2024 Citations: 2
Increased Prevalence of Attention Deficit Hyperactivity Disorder in Individuals with Selective Immunoglobulin A Deficiency: A Nationwide Case–Control Study E Merzon, R Farag, S Ashkenazi, E Magen, I Manor, A Weizman, I Green, ... Journal of Clinical Medicine 13 (20), 6075 , 2024 2024 Citations: 3
High rates of mood disorders in patients with chronic idiopathic eosinopenia E Magen, A Geishin, A Weizman, E Merzon, I Green, I Magen, A Yakov, ... Brain, Behavior, & Immunity-Health 40, 100847 , 2024 2024 Citations: 2
The influence of COVID-19 on attention-deficit/hyperactivity disorder diagnosis and treatment rates across age, gender, and socioeconomic status: A 20-year national cohort study VS Zemer, I Manor, A Weizman, HA Cohen, M Hoshen, NM Caspi, ... Psychiatry Research 339, 116077 , 2024 2024 Citations: 7
Predictors of valproic acid steady-state serum levels in adult and pediatric psychiatric inpatients: a comparative analysis M Avrahami, T Liwinski, Z Eckstein, M Peskin, P Perlman, J Sarlon, ... Psychopharmacology 241 (9), 1883-1894 , 2024 2024 Citations: 3
Efficacy of rotational field TMS in major depressive disorder–A pilot study S Hess, M Yeshua, A Eisen, Y Burnishev, E Sultan, G Pell, CA Hanlon, ... Brain Stimulation: Basic, Translational, and Clinical Research in … , 2024 2024 Citations: 1
Quetiapine in the treatment of comorbid burning mouth syndrome and bipolar II depression: case report M Poyurovsky, A Weizman Journal of Clinical Psychopharmacology 44 (4), 432-433 , 2024 2024 Citations: 2
Lymphoblast transcriptome analysis in 22q11. 2 deletion syndrome individuals with schizophrenia-spectrum disorder E Michaelovsky, M Carmel, D Gothelf, A Weizman The World Journal of Biological Psychiatry 25 (4), 242-254 , 2024 2024 Citations: 2
Increased rate of Familial mediterranean fever in children with ADHD: A Population-Based Case-Control study E Merzon, A Israel, B Krone, S Medvejer, S Cohen, I Green, ... Journal of Attention Disorders 28 (5), 669-676 , 2024 2024 Citations: 2
The Association Between Repeated Measured Febrile Episodes During Early Childhood and Attention Deficit Hyperactivity Disorder: A Large-Scale Population-Based Study A Israel, E Merzon, B Krone, SV Faraone, I Green, A Golan Cohen, ... Journal of Attention Disorders 28 (5), 677-685 , 2024 2024 Citations: 1
Psychopharmacology in children and adolescents: unmet needs and opportunities S Cortese, D Purper-Ouakil, A Apter, C Arango, I Baeza, T Banaschewski, ... The Lancet Psychiatry 11 (2), 143-154 , 2024 2024 Citations: 42
Lincoln H Holzer Douglas Debates , 2024 2024 Citations: 3
Characterizing the clinical and sociodemographic profiles of hospitalized adolescents with autism spectrum disorder M Avrahami, DH Ben-Dor, R Ratzon, A Weizman, PP Danieli Cambridge Prisms: Global Mental Health 11, e63 , 2024 2024 Citations: 1
The Association between Glucose 6-Phosphate Dehydrogenase Deficiency and Attention Deficit/Hyperactivity Disorder E Merzon, E Magen, S Ashkenazi, A Weizman, I Manor, B Krone, I Green, ... Nutrients 15 (23), 4948 , 2023 2023 Citations: 3
An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels J de Leon, G Schoretsanitis, RL Smith, E Molden, A Solismaa, N Seppälä, ... Psiquiatria Biologica 30 (3) , 2023 2023
Guía internacional para una dosificación más segura de la clozapina en adultos mediante el uso de 6 titulaciones personalizadas de dosis basados en la etnicidad, la proteína C … J de Leon, G Schoretsanitis, RL Smith, E Molden, A Solismaa, N Seppälä, ... Psiquiatría Biológica 30 (3), 100415 , 2023 2023 Citations: 1
MOST CITED SCHOLAR PUBLICATIONS
Development and validation of a machine learning‐based postpartum depression prediction model: A nationwide cohort study E Hochman, B Feldman, A Weizman, A Krivoy, S Gur, E Barzilay, H Gabay, ... Depression and anxiety 38 (4), 400-411 , 2021 2021 Citations: 133
The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study B Spivak, E Shabash, B Sheitman, A Weizman, R Mester Journal of Clinical Psychiatry 64 (7), 755-760 , 2003 2003 Citations: 110
Modulatory effects of cannabinoids on brain neurotransmission K Cohen, A Weizman, A Weinstein European Journal of Neuroscience 50 (3), 2322-2345 , 2019 2019 Citations: 109
Possible association between attention deficit hyperactivity disorder and attempted suicide in adolescents–a pilot study I Manor, I Gutnik, DH Ben-Dor, A Apter, J Sever, S Tyano, A Weizman, ... European Psychiatry 25 (3), 146-150 , 2010 2010 Citations: 106
Vitamin D supplementation in chronic schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled clinical trial A Krivoy, R Onn, Y Vilner, E Hochman, S Weizman, A Paz, S Hess, ... EBioMedicine 26, 138-145 , 2017 2017 Citations: 104
The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers R Inzelberg, OS Cohen, J Aharon-Peretz, I Schlesinger, ... Neurology 78 (11), 781-786 , 2012 2012 Citations: 104
Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan R Gross-Isseroff, R Cohen, Y Sasson, H Voet, J Zohar Neuropsychobiology 50 (3), 200-205 , 2004 2004 Citations: 104
Heat intolerance in patients with chronic schizophrenia maintained with antipsychotic drugs H Hermesh, R Shiloh, Y Epstein, H Manaim, A Weizman, H Munitz American Journal of Psychiatry 157 (8), 1327-1329 , 2000 2000 Citations: 104
Depression and suicidal behavior in adolescent inpatients with obsessive compulsive disorder A Apter, N Horesh, D Gothelf, G Zalsman, Z Erlich, N Soreni, A Weizman Journal of affective disorders 75 (2), 181-189 , 2003 2003 Citations: 102
Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia D Gothelf, N Soreni, RP Nachman, S Tyano, Y Hiss, O Reiner, A Weizman European Neuropsychopharmacology 10 (5), 389-395 , 2000 2000 Citations: 102
Methylphenidate treatment for attention-deficit/hyperactivity disorder in children and adolescents with velocardiofacial syndrome: an open-label study D Gothelf, R Gruber, G Presburger, I Dotan, A Brand-Gothelf, M Burg, ... Journal of Clinical Psychiatry 64 (10), 1163-1169 , 2003 2003 Citations: 101
Preferential transmission of interleukin-1 receptor antagonist alleles in attention deficit hyperactivity disorder RH Segman, A Meltzer, V Gross-Tsur, A Kosov, A Frisch, E Inbar, ... Molecular psychiatry 7 (1), 72-74 , 2002 2002 Citations: 101
Depressive symptoms and suicidality in physically abused children R Finzi, A Ram, D Shnit, D Har‐Even, S Tyano, A Weizman American Journal of Orthopsychiatry 71 (1), 98-107 , 2001 2001 Citations: 101
Olfactory sensitivity in major depressive disorder and obsessive compulsive disorder R Gross-Isseroff, K Luca-Haimovici, Y Sasson, S Kindler, M Kotler, ... Biological psychiatry 35 (10), 798-802 , 1994 1994 Citations: 101
Body image in social anxiety disorder, obsessive–compulsive disorder, and panic disorder IM Aderka, CA Gutner, A Lazarov, H Hermesh, SG Hofmann, S Marom Body image 11 (1), 51-56 , 2014 2014 Citations: 100
Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin: double-blind, placebo-controlled study M Poyurovsky, M Shardorodsky, C Fuchs, M Schneidman, A Weizman The British Journal of Psychiatry 174 (3), 238-242 , 1999 1999 Citations: 99
Double-blind comparison of cabergoline and bromocriptine in Parkinson's disease patients with motor fluctuations R Inzelberg, P Nisipeanu, JM Rabey, E Orlov, T Catz, S Kippervasser, ... Neurology 47 (3), 785-788 , 1996 1996 Citations: 99
Enhanced creative thinking under dopaminergic therapy in Parkinson disease A Faust‐Socher, YN Kenett, OS Cohen, S Hassin‐Baer, R Inzelberg Annals of neurology 75 (6), 935-942 , 2014 2014 Citations: 98
Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated … RD Strous, R Stryjer, R Maayan, G Gal, D Viglin, E Katz, D Eisner, ... Psychoneuroendocrinology 32 (2), 96-105 , 2007 2007 Citations: 98
The peripheral-type benzodiazepine receptor and tumorigenicity: isoquinoline binding protein (IBP) antisense knockdown in the C6 glioma cell line E Levin, A Premkumar, L Veenman, W Kugler, S Leschiner, I Spanier, ... Biochemistry 44 (29), 9924-9935 , 2005 2005 Citations: 98
